WorldQuant Millennium Advisors
WST icon

WorldQuant Millennium Advisors’s West Pharmaceutical WST Stock Holding History

WorldQuant Millennium Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Sell
8,421
-259,686
-97% -$79.4M 0.01% 466
2026
Q1 		$67.2M Buy
268,107
+253,914
+1,789% +$63.2M 0.26% 102
2025
Q4 		$3.91M Sell
14,193
-169,477
-92% -$46.4M 0.02% 353
2025
Q3 		$48.2M Sell
183,670
-129,651
-41% -$31.5M 0.21% 130
2025
Q2 		$68.6M Buy
313,321
+45,050
+17% +$9.63M 0.34% 76
2025
Q1 		$60.1M Buy
+268,271
New +$73.9M 0.38% 81
2024
Q2 		– Sell
-3,261
Closed -$1.29M – 478
2024
Q1 		$1.29M Buy
+3,261
New +$1.21M 0.02% 303
2023
Q1 		– Sell
-23,366
Closed -$5.5M – 416
2022
Q4 		$5.5M Sell
23,366
-15,497
-40% -$3.67M 0.13% 201
2022
Q3 		$9.56M Buy
+38,863
New +$11.8M 0.23% 132
2022
Q1 		– Sell
-3,707
Closed -$1.74M – 371
2021
Q4 		$1.74M Buy
+3,707
New +$1.6M 0.03% 267

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

WorldQuant Millennium Advisors's WST Position: Q2 2026 in Review

WorldQuant Millennium Advisors reduced its West Pharmaceutical (WST) stake by 97% in Q2 2026, selling an estimated $79.4M and leaving 8,421 shares worth $3.02M. The position accounts for 0.01% of the portfolio, ranked #466.

WorldQuant Millennium Advisors first reported a position in WST in Q4 2021 and has held it in 10 quarters since. The position peaked at $68.6M in Q2 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • WorldQuant Millennium Advisors held 8,421 shares of West Pharmaceutical worth $3.02M as of Q2 2026.
  • WorldQuant Millennium Advisors sold 259,686 West Pharmaceutical shares in Q2 2026, an estimated $79.4M.
  • West Pharmaceutical made up 0.01% of WorldQuant Millennium Advisors's portfolio in Q2 2026, its #466 holding.
  • WorldQuant Millennium Advisors first reported a position in West Pharmaceutical in Q4 2021 and has held it in 10 quarters since.
  • WorldQuant Millennium Advisors's West Pharmaceutical position peaked at $68.6M in Q2 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.